培托林里根因改善了呼吸道炎症和呼吸道重塑,以表现出抗咳作用
Quan He1, Weihua Liu2, Xiaomei Ma1
1Department of Respiratory and Critical Care Medicine, Zhenjiang Hospital of Integrated Traditional Chinese and Western Medicine, Zhenjiang, Jiangsu 212000, China.
概括
在小鼠模型中,pectolinarigenin (PEC) 通过减少肺损伤和炎症,有效抑制咳. 这种化合物可能为咳抑制提供一种新的治疗选择,其副作用比目前的治疗方法少.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 药物发现 药物发现 药物发现
背景情况:
- 频繁咳,从急性到慢性,显著影响患者的生活质量,并可能导致诸如咳变体喘等疾病.
- 目前的非处方止咳药物往往有严重的副作用,突出需要新的,更安全的止咳药.
- 培托林里根因 (PEC) 正在作为一种潜在的治疗剂来抑制咳进行研究.
研究的目的:
- 评价作为咳抑制剂的pectolinarigenin (PEC) 的药理作用.
- 调查PEC抗咳活性背后的潜在机制.
- 在咳模型中评估PEC对肺损伤,炎症和呼吸道改造的影响.
主要方法:
- 在BALB/c小鼠中建立了一种咳模型.
- 组织病理学分析 (血素-素,马森染色) 用于评估肺损伤和气道改造.
- 用ELISA和炎症细胞计数来测量炎症标志物和细胞透.
- 评估了空气道的超响应性,并使用西方涂抹来探索分子通路.
主要成果:
- 在咳模型中,PEC显著缓解了肺组织损伤,并减少了炎症因子释放.
- 该化合物抑制了咳频率和呼吸道壁中的原沉积.
- 通过抑制Ras/ERK/c-Fos信号通路,PEC表现出一种抗咳作用.
- 通过PEC治疗,气道炎症和高反应性减少.
结论:
- 在咳的小鼠模型中,pectolinarigenin (PEC) 显示出显著的抗咳特性.
- PEC可以缓解与慢性咳相关的肺损伤,炎症和气道改造.
- 拉斯/ERK/c-Fos途径与PEC的作用机制有关,这表明了一个新的治疗点.
- 在开发新的咳抑制药物方面,PEC是有前途的候选药物.
相关概念视频
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
276
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
276
01:19Antiasthma Drugs: Leukotriene Modifiers
281
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
281
01:24Antiasthma Drugs: Methylxanthines
220
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
220
01:17Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
169
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
169